Are invasive physiological measures necessary for an optimal setting of pressure support in young patients with cystic fibrosis?

F. Nicot, E. Sandrine, A. Clement, F. Lofaso, B. Fauroux (Paris, Le Kremlin Bicetre, Garches, France)

Source: Annual Congress 2003 - Physiology of NIV: understanding the effects and chosing the best settings
Session: Physiology of NIV: understanding the effects and chosing the best settings
Session type: Oral Presentation
Number: 1115
Disease area: Paediatric lung diseases, Respiratory critical care

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Nicot, E. Sandrine, A. Clement, F. Lofaso, B. Fauroux (Paris, Le Kremlin Bicetre, Garches, France). Are invasive physiological measures necessary for an optimal setting of pressure support in young patients with cystic fibrosis?. Eur Respir J 2003; 22: Suppl. 45, 1115

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of effective noninvasive positive pressure ventilation on inflammatory biomarkers in pediatric patients with cystic fibrosis.
Source: International Congress 2019 – Current trends in noninvasive ventilation for chronic respiratory failure
Year: 2019




Does an individualized long-term exercise training program affect the cardiorespiratory capacity and cardiac function in young patients with cystic fibrosis?
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019


Long term non invasive positive pressure ventilation is associated with a stabilisation in the decline of lung function in patients with cystic fibrosis
Source: Annual Congress 2006 - Interventions and outcome in chronic respiratory failure - new aspects and deeper insights
Year: 2006


Does large airway intervention for patients with malignant disease result in early clinical benefit?
Source: Annual Congress 2008 - Hot and cold techniques
Year: 2008


Clinical response to elexacaftor/tezacaftor/ivacaftor for cystic fibrosis patients in a compassionate use setting
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020


Can different approaches to anti-inflammatory therapy result in different outcomes in cystic fibrosis patients?
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007


Do causes influence clinical, functional and quality of life aspects on patients with bronchiectasis not associated with cystic fibrosis?
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019


Does the application of an algorithm for non-invasive ventilation in chronic obstructive pulmonary disease improve the initiation process, and patient outcomes?
Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure
Year: 2009


Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease
Source: Eur Respir J, 50 (4) 1701658; 10.1183/13993003.01658-2017
Year: 2017



Setting of noninvasive pressure support in young patients with cystic fibrosis
Source: Eur Respir J 2004; 24 : 624-630
Year: 2004



Does lung transplantation affect on the improvement of psychological status in patients with adult cystic fibrosis?
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018


Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series
Source: Eur Respir J 2006; 28: Suppl. 50, 263s
Year: 2006

Clinical and functional determinants of exercise limitation in adult patients with cystic fibrosis
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012

Does large airway intervention for patients with malignant disease result in early clinical benefit
Source: Eur Respir J 2007; 30: Suppl. 51, 434s
Year: 2007

Optimising treatment policies and improvement of care: impact on outcome in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 617s
Year: 2004

The value of lung function monitoring by means of a home monitor in patients with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011


A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021


AmbOx trial: does ambulatory oxygen improve quality of life in patients with fibrotic interstitial lung disease?
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017

The role of imagistic and functional methods in severity evaluation in children with cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis: better diagnosis, improved progress, but long-term complications
Year: 2007